212 related articles for article (PubMed ID: 38022675)
1. A novel ΔNp63-dependent immune mechanism improves prognosis of HPV-related head and neck cancer.
Mourtada J; Lony C; Nicol A; De Azevedo J; Bour C; Macabre C; Roncarati P; Ledrappier S; Schultz P; Borel C; Burgy M; Wasylyk B; Mellitzer G; Herfs M; Gaiddon C; Jung AC
Front Immunol; 2023; 14():1264093. PubMed ID: 38022675
[TBL] [Abstract][Full Text] [Related]
2. HPV-positive murine oral squamous cell carcinoma: development and characterization of a new mouse tumor model for immunological studies.
Modic Z; Cemazar M; Markelc B; Cör A; Sersa G; Kranjc Brezar S; Jesenko T
J Transl Med; 2023 Jun; 21(1):376. PubMed ID: 37296466
[TBL] [Abstract][Full Text] [Related]
3. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
4. Interplay between cancer cells and M2 macrophages is necessary for miR-550a-3-5p down-regulation-mediated HPV-positive OSCC progression.
Cao MX; Zhang WL; Yu XH; Wu JS; Qiao XW; Huang MC; Wang K; Wu JB; Tang YJ; Jiang J; Liang XH; Tang YL
J Exp Clin Cancer Res; 2020 Jun; 39(1):102. PubMed ID: 32493454
[TBL] [Abstract][Full Text] [Related]
5. Identification of an 8 HPV-related RNA signature as a novel prognostic biomarker for squamous cell carcinoma of the head and neck.
Mei Z; Zhengdong L; Shupeng L; Xin Z; Lei W; Wang C
Medicine (Baltimore); 2024 Feb; 103(6):e36448. PubMed ID: 38335428
[TBL] [Abstract][Full Text] [Related]
6. The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naïve tumors with immune checkpoint inhibitors.
Tosi A; Parisatto B; Menegaldo A; Spinato G; Guido M; Del Mistro A; Bussani R; Zanconati F; Tofanelli M; Tirelli G; Boscolo-Rizzo P; Rosato A
J Exp Clin Cancer Res; 2022 Sep; 41(1):279. PubMed ID: 36123711
[TBL] [Abstract][Full Text] [Related]
7. Localization and characterization of human papillomavirus-16 in oral squamous cell carcinoma.
Saleh W; Cha S; Banasser A; Fitzpatrick SG; Bhattacharyya I; Youssef JM; Anees MM; Elzahaby IA; Katz J
Oral Dis; 2023 Mar; 29(2):436-444. PubMed ID: 34022097
[TBL] [Abstract][Full Text] [Related]
8. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive Data of P53 R282 Gene Mutation with Human Papillomaviruses (HPV)-Associated Oral Squamous Cell Carcinoma (OSCC).
Ekalaksananan T; Wongjampa W; Phusingha P; Chuerduangphui J; Vatanasapt P; Promthet S; Patarapadungkit N; Pientong C
Pathol Oncol Res; 2020 Apr; 26(2):1191-1199. PubMed ID: 31197568
[TBL] [Abstract][Full Text] [Related]
10. Association between human papillomavirus and oral cancer: a literature review.
Shigeishi H
Int J Clin Oncol; 2023 Aug; 28(8):982-989. PubMed ID: 36929094
[TBL] [Abstract][Full Text] [Related]
11. CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma.
Wagner S; Wittekindt C; Reuschenbach M; Hennig B; Thevarajah M; Würdemann N; Prigge ES; von Knebel Doeberitz M; Dreyer T; Gattenlöhner S; Klussmann JP
Int J Cancer; 2016 May; 138(9):2263-73. PubMed ID: 26662627
[TBL] [Abstract][Full Text] [Related]
12. Dynamic changes of the EMT spectrum between circulating tumor cells and the tumor microenvironment in human papillomavirus-positive head and neck squamous cell carcinoma.
Ida S; Takahashi H; Tada H; Mito I; Matsuyama T; Chikamatsu K
Oral Oncol; 2023 Feb; 137():106296. PubMed ID: 36571985
[TBL] [Abstract][Full Text] [Related]
13. Detection of human papillomavirus infection in oral squamous cell carcinoma: a cohort study of Japanese patients.
Kouketsu A; Sato I; Abe S; Oikawa M; Shimizu Y; Takahashi T; Kumamoto H
J Oral Pathol Med; 2016 Sep; 45(8):565-72. PubMed ID: 26711722
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus-driven repression of NRF2 signalling confers chemo-radio sensitivity and predicts prognosis in head and neck squamous cell carcinoma.
Ramesh PS; Bovilla VR; Swamy VH; Manoli NN; Dasegowda KB; Siddegowda SM; Chandrashekarappa S; Somasundara VM; Kabekkodu SP; Rajesh R; Devegowda D; Thimmulappa RK
Free Radic Biol Med; 2023 Aug; 205():234-243. PubMed ID: 37328018
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
[No Abstract] [Full Text] [Related]
16. Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck Cancer.
Murphy RM; Tasoulas J; Porrello A; Carper MB; Tsai YH; Coffey AR; Kumar S; Zeng PY; Schrank TP; Midkiff BR; Cohen S; Salazar AH; Hayward MC; Hayes DN; Olshan A; Gupta GP; Nichols AC; Yarbrough WG; Pecot CV; Amelio AL
Cancer Res Commun; 2022 Sep; 2(9):987-1004. PubMed ID: 36148399
[TBL] [Abstract][Full Text] [Related]
17. Deciphering head and neck cancer microenvironment: Single-cell and spatial transcriptomics reveals human papillomavirus-associated differences.
Lee H; Park S; Yun JH; Seo C; Ahn JM; Cha HY; Shin YS; Park HR; Lee D; Roh J; Heo HJ; Baek SE; Kim EK; Lee HS; Kim CH; Kim YH; Jang JY
J Med Virol; 2024 Jan; 96(1):e29386. PubMed ID: 38235919
[TBL] [Abstract][Full Text] [Related]
18. Human papillomavirus and p53 expression in cancer of unknown primary in the head and neck region in relation to clinical outcome.
Sivars L; Näsman A; Tertipis N; Vlastos A; Ramqvist T; Dalianis T; Munck-Wikland E; Nordemar S
Cancer Med; 2014 Apr; 3(2):376-84. PubMed ID: 24510528
[TBL] [Abstract][Full Text] [Related]
19. Identification of the HNSC88 Molecular Signature for Predicting Subtypes of Head and Neck Cancer.
Chuang YH; Lin CY; Lee JC; Lee CH; Liu CL; Huang SH; Lee JY; Lai WS; Yang JM
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37685875
[TBL] [Abstract][Full Text] [Related]
20. Expression of Human Papillomavirus and the p16 Gene in Oral Potentially Malignant Disorders (OPMD): a Comparative Study With Oral Squamous Cell Carcinoma.
Baddevithana AK; Jayasinghe RD; Tilakaratne WM; Illeperuma RP; Siriwardena BSMS
Appl Immunohistochem Mol Morphol; 2023 May-Jun 01; 31(5):331-338. PubMed ID: 37036407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
